A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix

MLA

W P, Irvin, et al. “A Phase II Study of Irinotecan (CPT-11) in Patients with Advanced Squamous Cell Carcinoma of the Cervix.” Cancer, vol. 82, no. 2, Jan. 1998. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........144edf78ff4c63c300c1c7bcedbf31b5&authtype=sso&custid=ns315887.

APA

W P, I., F V, P., H, B., M, G., R, R., H J, D., & R K, P. (1998). A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix. Cancer, 82(2).

Chicago

W P, Irvin, Price F V, Bailey H, Gelder M, Rosenbluth R, Durivage H J, and Potkul R K. 1998. “A Phase II Study of Irinotecan (CPT-11) in Patients with Advanced Squamous Cell Carcinoma of the Cervix.” Cancer 82 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........144edf78ff4c63c300c1c7bcedbf31b5&authtype=sso&custid=ns315887.